CRISPR Therapeutics (CRSP) News Today $47.82 -0.74 (-1.52%) As of 11:19 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRSP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period CRISPR Therapeutics Enters Second Phase As CASGEVY Uptake And Data BuildMay 18 at 9:30 AM | finance.yahoo.comCRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data LoomsMay 15, 2026 | marketbeat.comVanguard Group Inc. Reduces Stock Position in CRISPR Therapeutics AG $CRSPMay 13, 2026 | marketbeat.comCRISPR Therapeutics AG (CRSP) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 12, 2026 | seekingalpha.comCRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Recommendation of "Moderate Buy" from BrokeragesMay 12, 2026 | americanbankingnews.comCRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Recommendation of "Moderate Buy" from AnalystsMay 12, 2026 | marketbeat.com1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?May 11, 2026 | fool.comNwam LLC Has $3.38 Million Position in CRISPR Therapeutics AG $CRSPMay 10, 2026 | marketbeat.comCRISPR Therapeutics (NASDAQ:CRSP) Upgraded to Hold at Wall Street ZenMay 9, 2026 | marketbeat.comCRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on ItMay 8, 2026 | finance.yahoo.comVRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 EarningsMay 8, 2026 | finance.yahoo.comQ2 EPS Estimate for CRISPR Therapeutics Boosted by AnalystMay 7, 2026 | marketbeat.comHC Wainwright Issues Positive Forecast for CRSP EarningsMay 7, 2026 | marketbeat.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: ADC Therapeutics (ADCT), Crispr Therapeutics AG (CRSP) and BioMarin Pharmaceutical (BMRN)May 6, 2026 | theglobeandmail.comCrispr Therapeutics AG (CRSP) Gets a Buy from Piper SandlerMay 6, 2026 | theglobeandmail.comChardan Capital Remains a Buy on Crispr Therapeutics AG (CRSP)May 6, 2026 | theglobeandmail.comCRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare ConferenceMay 6, 2026 | finance.yahoo.comIs It Time To Reconsider CRISPR Therapeutics (CRSP) After A 58% One Year Rally?May 6, 2026 | finance.yahoo.comCrispr Therapeutics Q1 Earnings: Casgevy Growth, H2 In-Vivo Catalysts Make Buy CaseMay 6, 2026 | seekingalpha.comCRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare ConferenceMay 6, 2026 | globenewswire.comFY2028 EPS Estimates for CRSP Decreased by AnalystMay 6, 2026 | marketbeat.comEquities Analysts Offer Predictions for CRSP FY2027 EarningsMay 6, 2026 | marketbeat.comCRISPR Therapeutics (NASDAQ:CRSP) Trading Down 6.1% - What's Next?May 5, 2026 | marketbeat.comCRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss EstimatesMay 5, 2026 | finance.yahoo.comVRTX's Q1 Earnings Beat Estimates, New Products Aid Sales GrowthMay 5, 2026 | finance.yahoo.comCRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Lags Revenue EstimatesMay 4, 2026 | finance.yahoo.comCRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial ResultsMay 4, 2026 | finance.yahoo.comCRISPR Therapeutics (NASDAQ:CRSP) Posts Earnings Results, Misses Estimates By $0.06 EPSMay 4, 2026 | marketbeat.comCRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial ResultsMay 4, 2026 | globenewswire.comCRISPR Therapeutics (CRSP) Projected to Post Quarterly Earnings on MondayMay 4, 2026 | marketbeat.comPictet Asset Management Holding SA Sells 25,129 Shares of CRISPR Therapeutics AG $CRSPMay 3, 2026 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Crispr Therapeutics AG (CRSP)May 1, 2026 | theglobeandmail.comUBS Group AG Boosts Stock Position in CRISPR Therapeutics AG $CRSPMay 1, 2026 | marketbeat.comWhy the Market Dipped But CRISPR Therapeutics AG (CRSP) Gained TodayApril 28, 2026 | finance.yahoo.comCRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseApril 28, 2026 | finance.yahoo.comCRISPR Therapeutics (NASDAQ:CRSP) Shares Up 7.5% - Here's WhyApril 27, 2026 | marketbeat.comCRISPR Therapeutics to Report Q1 Earnings: Is a Beat in the Cards?April 27, 2026 | finance.yahoo.com3 Biotech Stocks That Could Benefit from the Patent CliffBiotech M&A is surging ahead of a $300B patent cliff. Here are 3 gene-editing stocks investors are watching as potential acquisition targets...April 27, 2026 | marketbeat.comCRISPR Therapeutics (NASDAQ:CRSP) Shares Down 7.5% - Here's WhyApril 24, 2026 | marketbeat.comCathie Wood Is Loading Up on These 3 Next-Gen Tech StocksApril 23, 2026 | 247wallst.comCRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key FactsApril 23, 2026 | finance.yahoo.comCRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key FactsApril 22, 2026 | finance.yahoo.comInvestors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to KnowApril 21, 2026 | finance.yahoo.comAssessing CRISPR Therapeutics (CRSP) Valuation After Recent Share Price PerformanceApril 21, 2026 | finance.yahoo.comWealth Enhancement Trust Services Inc. Takes Position in CRISPR Therapeutics AG $CRSPApril 19, 2026 | marketbeat.comCRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should KnowApril 16, 2026 | finance.yahoo.comCRISPR Therapeutics AG (CRSP) Presents at 25th Annual Needham Virtual Healthcare Conference TranscriptApril 13, 2026 | seekingalpha.com2 Billion Reasons to Love CRISPR Therapeutics Right NowApril 13, 2026 | fool.comCRISPR Therapeutics Touts “Second Phase” After Casgevy, Eyes 6 Data Readouts in 6–12 MonthsApril 13, 2026 | marketbeat.comColossal’s Ben Lamm Says Invasive Species Is a $5.4 Trillion Problem. Here’s His SolutionApril 12, 2026 | 247wallst.com Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRSP Media Mentions By Week CRSP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRSP News Sentiment▼0.660.35▲Average Medical News Sentiment CRSP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRSP Articles This Week▼49▲CRSP Articles Average Week Get the Latest News and Ratings for CRSP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CRISPR Therapeutics and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Allogene Therapeutics News Axsome Therapeutics News Beam Therapeutics News Editas Medicine News KALA BIO News Moderna News Intellia Therapeutics News Vertex Pharmaceuticals News Roivant Sciences News Viatris News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRSP) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
